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Abstract
Background: Global analyses of human disease genes by computational methods have yielded
important advances in the understanding of human diseases. Generally these studies have treated
the group of disease genes uniformly, thus ignoring the type of disease-causing mutations (dominant
or recessive). In this report we present a comprehensive study of the evolutionary history of
autosomal disease genes separated by mode of inheritance.
Results: We examine differences in protein and coding sequence conservation between dominant
and recessive human disease genes. Our analysis shows that disease genes affected by dominant
mutations are more conserved than those affected by recessive mutations. This could be a
consequence of the fact that recessive mutations remain hidden from selection while heterozygous.
Furthermore, we employ functional annotation analysis and investigations into disease severity to
support this hypothesis.
Conclusion: This study elucidates important differences between dominantly- and recessively-
acting disease genes in terms of protein and DNA sequence conservation, paralogy and essentiality.
We propose that the division of disease genes by mode of inheritance will enhance both
understanding of the disease process and prediction of candidate disease genes in the future.
Background
Understanding the genetic basis of human inherited dis-
orders is one of the primary goals of medical genetics. By
applying the knowledge gleaned from this research, dis-
ease prevention and treatment can be improved. Cur-
rently, there are more than 1600 human genes known to
be associated with particular Mendelian disease pheno-
types. The analysis of this group of genes from a global
perspective has already revealed interesting insights about
the nature of human disease [1-5].
Several reports have analysed the conservation pattern of
disease genes compared to the rest of genes [2-7]. Human
disease genes have been found to be more conserved at
the protein level, in general, than the remainder of the
human proteome [2], and most have been found to pos-
sess homologues in the mouse and rat genomes [3]. Fur-
thermore, a study of human genes involved in disease
found lower non-synonymous substitution rate (KA) in
the disease genes compared to generic genes [5]. Another
study of sequence conservation at the nucleotide level
between human and rat found only a small difference
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between the KA/KS ratio of human disease genes and non-
disease genes, although a significantly more elevated syn-
onymous substitution rate (KS) in the disease genes was
discovered [3]. Analysis of the chimpanzee genome also
found a higher synonymous substitution rate in disease
genes that was attributed to a higher relative frequency of
CpG dinucleotides [6]. Recently another work reported
the analysis of human-rodent KA/KS ratios of disease genes
compared to housekeeping and the rest of genes, finding
that housekeeping genes are the most conserved group
with disease genes showing intermediate values between
the housekeeping and other genes [7].
These studies have treated the disease genes as homogene-
ous datasets and in doing so have neglected an inherent
difference within the sets of genes, namely the molecular
genotype underlying the disease state. Many autosomal
Mendelian disease phenotypes can be understood in
terms of dominant and recessive mutations affecting a
particular gene. In cases in which the mutation is said to
be dominantly-acting, a mutation to a single allele of the
gene is sufficient to cause the disease state. Genes suscep-
tible to disease-causing mutations in this way are often
haploinsufficient. The mutation can cause loss of function
of the protein by dominant negative effects, or reduced or
compromised functioning. Diseases caused by recessive
mutations require both alleles to be affected, as the pro-
duction of a functional protein from one allele is often
enough to satisfy physiological requirements (haplosuffi-
ciency).
The phenomenon of dominance and recessitivity in dip-
loid organisms was first recorded quantitatively by Gregor
Mendel in 1866 [8], and the evolution of dominance has
been a topic of debate between geneticists for the last cen-
tury [9]. Fisher, in 1928, reported that most mutations
observed in Drosophila were recessive to the wild-type
alleles [10]. He attributed this to a balance between recur-
rent mutations and their elimination by natural selection.
However, Wright (1929) challenged this hypothesis stat-
ing that unrealistically high levels of selective pressure
were necessary for the evolution of dominance in this
manner [11]. He proposed that dominance was an inher-
ent consequence of physiology. Kascer and Burns (1981)
developed a metabolic model for dominance congruent
with Wright's physiological model [12]. However, the
metabolic model has been criticised because it is solely
based on the kinetic properties of metabolic enzymes
[13].
Previous studies have analysed human disease genes in
terms of the nature of the mutation underlying the disease
phenotype [1,2,5]. However the focus of these studies has
been mainly on differences in the functional classification
of dominant and recessive disease genes. Jimenez-
Sanchez et al. showed that diseases caused by genes cod-
ing for enzymes were predominantly recessive, whereas
disorders in which the causative gene coded for a tran-
scription factor were, in the main, dominantly-acting [1].
Lopez-Bigas et al. have reported similar results and further
demonstrate that dominant human disease genes have
closer paralogues than recessive disease genes [14]. Kon-
drashov and Koonin reported that haploinsufficient
(dominant) disease genes have more paralogues in the
human genome than haplosufficient (recessive) genes
[15].
However, none of these studies has investigated differ-
ences in sequence conservation between disease genes
depending on their mode of inheritance. Smith and Eyre-
Walker [4] analyse gene evolution in the Jimenez-Sanchez
et al. dataset and report higher conservation in dominant
disease genes compared to recessive disease genes, but this
study also observes less selective constraints on disease
genes compared to non-disease genes, a result that is con-
trary to evidence from other reports, and could be due to
the small number of genes analysed [5].
We have undertaken a comprehensive study of the molec-
ular evolution of the autosomal human disease genes
depending on their mode of inheritance; namely genes
affected by dominant mutations and by recessive muta-
tions. We have investigated differences in coding
sequence divergence, protein conservation, human paral-
ogy, C. elegans lethality, protein function, gene structure
and severity of disease. The comparison of the evolution-
ary patterns of dominant and recessive disease genes
reveals important differences between these two sets of
genes that can be understood in terms of their different
hereditary nature, giving further insights into the under-
standing of hereditary human diseases.
Results
Differences in level of protein conservation between 
disease proteins affected by dominant or recessive 
mutations
The division of disease genes reveals that depending on
the mode of inheritance the level of conservation of the
protein is different. Human proteins encoded by genes
affected by dominant mutations are more conserved in
mouse than those encoded by genes affected by recessive
mutations (p-value for Mann-Whitney (M-W) test = 7.59
× 10-6; Tables 1 &2). When we plot the frequency distribu-
tions of the protein conservation scores (cs, see Methods)
of the different sets of genes, we observe that the set of
dominant disease genes (DD) has a significantly different
distribution to recessive disease genes (DR) (p-value for
Kolmogorov-Smirnov (K-S) test = 1.95 × 10-6, Table 2 and
Figure 1) and both sets of disease genes are significantly
different to the non-disease genes (p-value for both K-SBMC Genomics 2006, 7:165 http://www.biomedcentral.com/1471-2164/7/165
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tests < 2.2 × 10-16). Recessive disease genes display a sharp
decrease in frequency at high levels of protein conserva-
tion scores (cs > 0.9), a trend not apparent in dominant
disease or non-disease genes. Consistent results are
observed with the analysis of cs in other vertebrates,
namely Rattus norvegicus, Gallus gallus, Takifugu rubripes,
and Danio rerio [see Additional file 1].
Level of protein conservation of paralogues of dominant 
and recessive disease genes
Previously, it has been reported that genes involved in dis-
ease have less conserved paralogues than human genes in
general [2], presumably because highly similar paralogues
can potentially compensate for a mutated protein [16], in
which case a disease might not be observed. This is con-
firmed by our analysis, in which the average conservation
score (cs) of paralogues is 0.349 for human disease genes
and 0.385 for non-disease genes (p-value for M-W test =
5.24 × 10-4, Tables 1 &2). However, by classifying the dis-
ease genes by the mode of inheritance of the phenotype,
we can see that significant differences are observed
between genes involved in dominant or recessive diseases
(p-value for M-W test = 4.44 × 10-16; Tables 1 and 2), in
congruence with previous results [14]. The average cs
value of paralogues of recessive disease genes is 0.295,
while that of dominant disease genes is 0.420, even higher
than for the non-disease genes. However, when we exam-
ine the sequence conservation pattern of paralogues more
closely, we observe that non-disease genes have a higher
proportion of highly similar paralogues (cs > 0.8) than
either of the disease gene groups (Figure 2). This differ-
ence is more pronounced in recessive than in dominant
disease genes. To assess these differences statistically we
calculated Z-scores and p-values for dominant and reces-
sive disease genes against 10,000 randomly generated sets
of proteins. Recessive disease genes have a significantly
lower than expected number of highly conserved para-
logues (Z-score = -2.76, p-value = 2 × 10-3 for cs > 0.8). The
number of dominant disease gene paralogues with cs >
0.8 is, however, not significantly different to that expected
by random sampling of the proteins. In conclusion, the
lower number of less conserved paralogues in disease ver-
sus non-disease genes can be entirely attributed to the
recessive disease genes.
Selective pressures acting on dominant and recessive 
disease genes at the DNA level
We analysed the level of conservation at the DNA level of
these sets of genes in order to obtain a better understand-
ing of the selective pressures acting on them. We exam-
Table 1: Molecular evolution and paralogy of disease genes involved in dominant and recessive diseases at protein level. Average values 
for mouse and paralogues conservation score for different sets of genes.
CS mouse n CS paralogues n
Non disease 0.730 16789 0.385 17962
Disease 0.795 1105 0.349 1108
Disease Dominant 0.810 474 0.420 478
Disease Recessive 0.783 631 0.295 630
Table 2: p-values for Mann-Whitney and Kolmogorov-Smirnoff test that asses the statistical significance of the differences between the 
averages and distributions of the groups.
Mann-Whitney Test
CS mouse CS paralogs KA KS KI
nD vs Dis <2.2 e-16 3.38 e-04 0.170 1.36 e-10 0.260
nD vs DD <2.2 e-16 5.24 e-04 6.37 e-04 8.34 e-07 0.567
nD vs DR 2.08 e-11 5.34 e-15 2.99 e-06 1.05 e-05 0.309
DD vs DR 7.59 e-06 4.44 e-16 7.17 e-11 0.212 0.798
Kolmogorov-Smirnoff Test
CS mouse CS paralogs KA KS KA/KS
nD vs Dis <2.2 e-16 1.56 e-05 4.70 e-05 1.12 e-09 <2.2 e-16
nD vs DD <2.2 e-16 8.70 e-08 7.98 e-05 3.06 e-04 <2.2 e-16
nD vs DR <2.2 e-16 1.86 e-10 2.66 e-10 2.20 e-07 <2.2 e-16
DD vs DR 1.95 e-06 1.84 e-13 1.26 e-11 0.122 2.65 e-10BMC Genomics 2006, 7:165 http://www.biomedcentral.com/1471-2164/7/165
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ined non-synonymous (KA) and synonymous (KS) coding
sequence substitution rates, as well as intron sequence
substitution rates (KI), from human-chimpanzee ortho-
logues [6]. KA is indicative of the selective pressure acting
on sites that involve a change of amino acid, while KS is
more reflective of the background mutation level. Disease
genes taken together show lower KA values than non-dis-
ease genes (average KA 0.00295 vs. 0.00318, Table 3), in
agreement with previous results [5]. However, the strong-
est differences are found between the two types of disease
genes (M-W test p-value = 7.17 × 10-11), with an average
KA of 0.0026 for dominant disease genes and of 0.0032 for
recessive disease genes (Table 3, Figure 3A). Dominant
disease genes are thus evolving more slowly, in general,
than recessive disease genes or non-disease genes, which
indicates that they are subjected to stronger selective con-
straints. Interestingly, although the average value of KA
between disease recessive and non-disease genes is very
similar (0.00320 and 0.00318), the distribution of KA val-
ues for these two sets is clearly different (p-value for K-S
test = 2.66 × 10-10 and Figure 3A). In fact, we observe a
much lower proportion of disease recessive genes with
very low KA value (<0.001) while intermediate KA values
are over-represented in this group of genes (Figure 3). This
is in agreement with the observed distribution of conser-
vation scores (Figure 1) in which an under-representation
of recessive disease genes is observed for very high conser-
vation scores.
Disease genes show higher KS values, for both dominant
and recessive genes, than the rest of human genes (p-value
for M-W test disease versus non-disease = 8.34 × 10-7 Fig-
ure 3B, Table 3). These differences could be ascribed to
varying mutation rates in the genome, however the simi-
larity in mean KI values (Table 3) and non-significant dif-
ferences for the Mann-Whitney test (Table 2) for all
groups would seem to negate this. Huang et al. reported a
significantly elevated KS level in human disease genes
compared to non-disease genes in an analysis between
human and rat genes [3]. This phenomenon was also dis-
covered in the analysis of the chimpanzee genome [6].
Due to the differences observed in KS between disease and
non-disease genes it is necessary to analyse any differences
in the ratio KA/KS between these groups of genes. This
analysis confirms that, as observed in the conservation
score and KA analyses, dominant disease genes exhibit the
lowest evolutionary rates (Figure 3C, Table 3), while dis-
ease recessive genes have a similar average KA/KS value to
the rest of genes (nD), although the distribution of KA/KS
values between these two groups of genes is again very dif-
ferent (p-value for K-S test < 2.2 × 10-16).
Consistent results are found in the analysis of KA, KS, and
KA/KS in human-mouse-dog orthologues [see Additional
file 2].
Essentiality in dominant and recessive disease genes
Our analysis shows that recessive disease genes are under-
represented among highly conserved genes. One possibil-
ity is that in highly conserved proteins the occurrence of
double mutations, as observed in recessive disease genes,
is often associated with lethality, in which case a disease
condition will not be observed. To assess this we mapped
the genes from our study to C. elegans gene orthologues
that have been previously classified as Wild Type (WT),
disease (D) or Lethal (L) according to RNAi data [17].
Genes that are lethal when disrupted are considered
"essential genes".
Conservation of dominant and recessive disease genes at  protein level Figure 1
Conservation of dominant and recessive disease 
genes at protein level. Distribution of conservation score 
in mouse of dominant and recessive disease genes versus the 
rest of genes.
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Table 3: Molecular evolution of disease and non-disease genes. Average values for KA, KS, KI and KA/KS for different sets of genes.
KA KS KI KA/KS n
Non disease 0.00318 0.01400 0.01260 0.220 10914
Disease 0.00295 0.01644 0.01270 0.194 886
Disease Dominant 0.00260 0.01790 0.01274 0.157 367
Disease Recessive 0.00320 0.01540 0.01266 0.222 519BMC Genomics 2006, 7:165 http://www.biomedcentral.com/1471-2164/7/165
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Firstly we determined that essential genes are significantly
more conserved than WT genes (cs human-mouse: WT =
0.80, L = 0.84, p-value M-W test = 6.79 × 10-6; KA human-
chimpanzee orthologues: WT = 0.0019, L = 0.0013, p-
value M-W test = 2.19 × 10-8). The next question was
whether recessive disease genes were under-represented
among essential genes. The data show that the set of reces-
sive disease genes has a lower proportion of C. elegans
essential genes (31%) than the set of dominant disease
genes (36%). In addition, only 47% of dominant disease
orthologues have no phenotypic effect (WT) when
mutated, in comparison to 61% of recessive disease ortho-
logues and 58% of non-disease gene orthologues.
Evolutionary conservation rates by functional annotations
Previously it has been found that the proportions of dif-
ferent functional annotations in dominant and recessive
disease genes are not the same [1,14,15]. Diseases caused
by mutations in genes coding for enzymes and transport-
ers are mostly recessive, while mutations in transcription
regulators, structural molecules, nucleic acid binding
genes and signal transducers are primarily dominant.
Therefore, it could be that the differences in evolutionary
rates between dominant and recessive disease genes are
due to the dissimilarities between the different types of
functional genes and not due to distinct evolutionary his-
tories of these two sets of genes. In order to rule out this
possibility each human disease gene was classified accord-
ing to the molecular function of its protein product as
determined by Gene Ontology (GO) 'slim' terms [18],
and the conservation score in mouse and KA/KS values
between human and chimpanzee of dominant and reces-
sive disease genes in each of the functional annotations
were assessed (Table 4). Despite the variation in conserva-
tion values observed between the different functional clas-
sifications, we observe consistently higher conservation
scores and lower KA/KS values (Table 4) in the set of dom-
Evolutionary rates between human and chimpanzee genes of  dominant and recessive disease genes at DNA level Figure 3
Evolutionary rates between human and chimpanzee 
genes of dominant and recessive disease genes at 
DNA level. (A) Distribution of KA for disease genes versus 
the rest of genes. (B) Distribution of KS for disease genes 
versus the rest of genes. (C) Distribution of KA/KS ratio of 
disease genes versus the rest of genes.
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inant disease genes compared to the recessive disease
genes. These results confirm that the evolutionary differ-
ences observed between dominant and recessive disease
genes are due to different selective pressures acting on
these two sets of genes during their history and not simply
due to varying proportions of functionally dissimilar
genes in each group.
In addition, when paralogues of dominant and recessive
disease genes are similarly analysed, the higher conserva-
tion of dominant disease gene paralogues is evident in
each functional group (Table 4).
Evolutionary conservation rates by severity of disease
Analysis of the evolutionary constraints of disease genes,
as indicated by human-chimpanzee KA/KS values, when
categorised by the severity of disease displays a trend of
reduction in selective pressure with decreasing severity of
disease (Table 5). While this pattern is clearly evident in
recessive disease genes, it appears to be more complicated
in dominant disease genes. However, disease genes of
both modes of inheritance that result in severe pheno-
types (i.e. death before reproductive age) are more con-
served than genes in which the consequent disease does
not severely affect the reproductive fitness of an individ-
ual.
Gene structure of autosomal dominant and recessive 
disease genes
Previously, it has been found that genes involved in
hereditary diseases have different gene structure proper-
ties compared to the rest of genes in the human genome
[2,19]. In particular, disease genes have longer coding
sequences, more exons and more alternative splicing [19].
Table 4: Mean CS in mouse, in paralogues and KA/KS values for dominant and recessive disease genes by GO slim category
CS mouse
nD Disease Disease dominant Disease recessive
Enzyme regulation 0.778 0.790 0.818 0.755
Transcription regulation 0.800 0.860 0.871 0.824
Nucleic acid binding 0.795 0.835 0.851 0.803
Catalysis 0.809 0.819 0.832 0.815
Signal transduction 0.751 0.748 0.776 0.708
Structural molecule 0.828 0.831 0.838 0.815
Transporter 0.824 0.848 0.862 0.841
Carrier 0.838 0.881 0.884 0.880
CS paralogues
nD Disease Disease dominant Disease recessive
Enzyme regulation 0.374 0.272 0.300 0.236
Transcription regulation 0.353 0.422 0.440 0.359
Nucleic acid binding 0.358 0.370 0.431 0.250
Catalysis 0.381 0.355 0.430 0.331
Signal transduction 0.383 0.347 0.406 0.261
Structural molecule 0.449 0.482 0.595 0.207
Transporter 0.424 0.400 0.539 0.331
Carrier 0.425 0.432 0.571 0.402
KA/KS chimpazee
nD Disease Disease dominant Disease recessive
Enzyme regulation 0.163 0.233 0.223 0.251
Transcription regulation 0.170 0.144 0.109 0.253
Nucleic acid binding 0.188 0.164 0.149 0.190
Catalysis 0.185 0.179 0.150 0.189
Signal transduction 0.213 0.173 0.138 0.238
Structural molecule 0.201 0.183 0.155 0.250
Transporter 0.176 0.166 0.082 0.213
Carrier 0.170 0.197 0.123 0.213BMC Genomics 2006, 7:165 http://www.biomedcentral.com/1471-2164/7/165
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These specific sequence properties are thought to be due
to the higher probability of suffering disease-causing
mutations of genes that are longer and have more com-
plex splicing patterns [19]. We analysed the structure of
genes involved in autosomal dominant and recessive dis-
eases to elucidate any differences between the two groups.
We have confirmed previous results, finding that the
group of disease genes has, on average, a higher number
of exons (D = 13.53, nD = 9.77), a higher number of alter-
native transcripts (D = 5.03, nD = 4.47), and a longer gene
sequence (D = 62818 and nD = 52066) and coding
sequence (D = 657.2 and nD = 509.6) compared to the
complete set of human genes. All these differences have
been tested using the Mann-Whitney and Kolmogorov-
Smirnov tests and are significant. A similar analysis com-
paring the set of genes involved in autosomal recessive or
dominant diseases shows no significant differences in the
protein or gene length or in the number of alternative
transcripts between these two sets of genes. However,
there is a marginally statistically significant difference in
the number of exons (DD = 13.65, DR = 14.63; p-value for
M-W test = 8.5 × 10-4).
Discussion
Our analysis reveals that the selective pressures on human
autosomal disease genes involved in dominant and reces-
sive disorders differ significantly. Dominantly-acting dis-
ease genes appear to be more conserved than recessively-
acting genes. In addition, we have confirmed previous
results showing that disease genes are generally more evo-
lutionarily conserved than other human genes [2,5,6].
Previously it has been found that the proportions of dif-
ferent functional annotations in dominant and recessive
disease genes differ substantially [1,14,15]. Therefore, it
could be that the nature of the conservation pattern is
determined solely by the function of the protein. However
analysis of the conservation levels for the two groups of
disease genes within each GO slim functional category
(Table 4) would appear to refute this, as in all categories,
dominant disease genes are consistently more conserved
than recessive disease genes. Other factors have been
shown to correlate with the protein evolutionary rate. In a
recent report it has been shown that the age of a protein is
inversely correlated with its evolutionary rate, that is, that
older proteins evolve more slowly than proteins of more
recent origin [20]. However, we have found that, in spite
of the fact that recessive disease genes show higher evolu-
tionary rates, they are better represented among old genes
than dominant disease genes [see Additional file 3].
Overall, the results presented here show that the mode of
inheritance of a gene is an important determinant of its
rate of evolution. According to the nearly neutral theory of
evolution slightly deleterious mutations may become
fixed in populations [21]. Recessive genes should accumu-
late a larger number of such mutations than dominant
genes, as in the former the mutant will be "hidden" from
selection while heterozygous [22]. A higher fixation rate
of slightly deleterious mutations in recessive genes would
result in higher KA/KS ratios in this type of gene [4].
Analyses of the conservation levels of genes involved in
recessive diseases have shown a significant decrease in fre-
quency at high levels of conservation (high conservation
score (Figure 1) or low KA/KS ratio (Figure 3C)). The most
plausible explanation for this effect is that genes with high
degree of conservation may be enriched for human essen-
tial genes, which cannot be involved in a recessive disease
since a double mutation in them would be lethal. The
analysis of RNAi phenotypes in C. elegans of human
orthologues for the three groups of genes analysed sup-
ports this. We find that a slightly higher proportion of
lethal genes in the set of dominant disease genes and a
higher proportion of genes with no effect (WT) in the
recessive disease set. However, we still find a considerable
proportion of genes that are essential in C. elegans but
classified as recessive disease genes in human. This may be
due to the fact that, although the set of essential genes in
C. elegans is likely to be enriched with human essential
genes, there will also be cases in which the gene is essen-
tial in C. elegans but not in humans.
It has been suggested that essential genes should evolve at
slower rates than non-essential genes [23]. Certainly, pre-
vious works have shown that essential genes in bacteria
[24] and yeast [25] are highly conserved, although there
have been some controversial results [26,27]. We have
found that the level of conservation of human genes tends
Table 5: KA/KS mean values by mode of inheritance according to severity of disease: None, Mild (death >60 years), Moderate (death 
between puberty and 60), and Severe (death before puberty).
n Disease Disease dominant Disease recessive
None 99 0.186 0.133 0.224
Mild 36 0.167 0.114 0.215
Moderate 90 0.182 0.152 0.209
Severe 78 0.168 0.110 0.186BMC Genomics 2006, 7:165 http://www.biomedcentral.com/1471-2164/7/165
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to be higher when the corresponding orthologue in C. ele-
gans is essential than when it is not lethal. This supports
the hypothesis that the sharp decrease of recessive disease
genes at high conservation levels could be related to the
paucity of human essential genes in the recessive disease
set.
Therefore, it is possible that the greater degree of conser-
vation exhibited by dominant disease genes vs. recessive
disease genes is an effect of the higher likelihood of fixa-
tion of slightly deleterious non-synonymous mutations in
the recessive disease genes coupled with an under-repre-
sentation of highly conserved genes in this same dataset.
In addition, we analysed the conservation of disease genes
according to the severity of the disease (Table 5). Our
analysis reveals that the conservation of both dominant
and recessive disease genes is highest in the category in
which disease results in death before the onset of puberty,
i.e. reproductive fitness equal to zero from a population
genetics perspective. We acknowledge that the partition of
disease genes into these rudimentary groups is a simplifi-
cation, however, it serves to give insight into the relation-
ship between disease severity and selective constraints.
We have also confirmed that disease genes show higher KS
values, for both dominant and recessive genes, than the
rest of human genes (Figure 3B, Table 3). Huang et al.
reported similar results in an analysis between human
and rat genes [3], and this phenomenon was also discov-
ered in the analysis of the chimpanzee genome [6]. Fur-
thermore, in this analysis the authors ascribe the higher KS
level in disease genes to the more abundant presence of
the mutation-susceptible CpG dinucleotide in disease
genes. They report that when CpG dinucleotides are
excluded from the analysis, the difference in KS rates
between the two sets of genes becomes non-significant.
The tendency of non-disease genes to have closer para-
logues than disease genes has previously been attributed
to the fact that a close paralogue may be able to ameliorate
the effect of a loss-of-function mutation in a gene by vir-
tue of its similar functionality [16]. We find that recessive
disease genes, which contain mainly loss-of-function
mutations, have a deficit in close paralogues that could
compensate for the loss of function. On the contrary,
dominant disease genes, although possessing closer and
hence more functionally similar paralogues, may not be
reprieved from a disease state by the existence of close par-
alogues due to their dominant-negative effects. In addi-
tion, haploinsufficient genes (i.e. dominant disease) may
be more dosage-dependent, in which case retention of
paralogues may be advantageous [15]. However, the dif-
ference observed between the two groups of disease genes
could also be due to less selective pressure on a recessive
disease gene after gene duplication. Alternatively, gene
duplications in dominant disease genes could be more
recent than similar events in recessive disease genes. As
can seen in Table 4, the difference in the conservation
level of paralogues is not determined by protein function.
In this study we have focused on autosomal genes that are
affected by recessively- and dominantly-acting mutations
that lead to a disease phenotype. We readily acknowledge
that we do not highlight other relevant groups of genes
such as X-linked disease genes and imprinted genes
[28,29]. However, cursory evidence of X-linked disease
gene evolution is included [see Additional file 4].
Conclusion
We highlight significant differences between disease
genes, in terms of protein and DNA sequence conserva-
tion, paralogy and essentiality, when categorised by their
mode of inheritance.
Our analysis reveals that genes affected by dominant dis-
ease mutations are more conserved than recessive disease
genes. We attribute this to the fact that recessive mutations
remain hidden from selection while heterozygous, which
would allow recessive disease genes to accumulate a larger
number of slightly deleterious mutations that eventually
could become fixed in populations.
A number of studies have attempted to predict disease
genes computationally using features such as sequence
length, paralogy, sequence conservation, range of tissue
expression, amino-acid composition and splicing signals
among others [2,4,5,30]. These studies have treated dis-
ease genes as a homogeneous dataset. We suggest that the
differences between dominant and recessive disease genes
should be accounted for in future disease gene-prediction
studies.
Methods
Data
Genes involved in hereditary disease are catalogued in The
Online database of Mendelian Inheritance in Man
(OMIM) [31]. We retrieved the list of genes from the 'mor-
bid map' table in OMIM database. Using the NCBI
LocusLink [32] database and the Ensembl database [33],
we located the corresponding gene sequence records. The
result is a list of 1647 genes associated with human dis-
ease. All other Ensembl protein-coding genes were classi-
fied as non-disease (nD). Disease genes were classified
according to the mode of inheritance of the disease they
cause using text mining automatic extraction from the
clinical synopsis section in OMIM database and manual
curation as reported in [14]. Genes were classified as auto-
somal Disease Dominant (DD; n = 498) if a mutation in
a single allele has been reported as causative of a geneticBMC Genomics 2006, 7:165 http://www.biomedcentral.com/1471-2164/7/165
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disorder, autosomal Disease Recessive (DR; n = 662) if
mutations in both alleles are required for the disease phe-
notype, and Others (e.g. X-linked diseases) as described
previously. Genes in which both type of mutations (dom-
inant and recessive) have been found were not used in the
study.
Calcultation of conservation score
Conservation score (cs) is an estimation of the divergence
that has occurred between a pair of proteins during evolu-
tion, and is independent of the length of the proteins [2].
This score provides not only an estimation of the non-syn-
onymous nucleotide substitution rate between a pair of
proteins, but also takes into account the conservativeness
of amino acid substitutions. Conservation scores were cal-
culated using WUBLASTP (version 2.0) [34], which is
based on the public domain NCBI BLAST version 1.4 [35].
Hits with E-values > 1 × 10-10 were discarded. Smith-
Waterman [36] alignment was performed on the pairs
that gave a significant BLAST hit. The value of cs was cal-
culated for each of the datasets DD, DR and nD using the
relevant human protein-coding sequence in Ensembl ver-
sion 34 as the WUBLASTP score of the closest homologue
in the Mus musculus divided by the WUBLASTP score of
the protein against itself, as reported elsewhere [37]. Sim-
ilarly, the conservation score of paralogues was calculated
as the WUBLASTP score of the closest paralogue divided
by the WUBLASTP score of the protein against itself.
To assess the statistical significance of the results we com-
puted two non-parametric statistical tests, the Kol-
mogorov-Smirnov (K-S) test and the Mann-Whitney (M-
W) test, using the R statistics package [38]. To test whether
there was a significant deviation from random expectation
of the number of paralogues of dominant and recessive
disease genes (X) at high levels of conservation (cs > 0.8)
we randomly generated 10,000 datasets of proteins of
identical sample size to the dominant and to the recessive
disease gene datasets and counted in each set the number
of genes with paralogues with cs higher than the threshold
(0.8). Z-scores {Zx = (X - μx)/σx} and p-values {px = Σ(nx ≥
X)/N} were calculated (where mean = μx, standard devia-
tion = σx, nx is the number of sets that score above the
threshold X and N the total number of datasets)
Calculation of nucleotide substitution rates at DNA level
The set of 13,454 human-chimpanzee orthologues used
for gene evolution analysis by the Chimpanzee Sequenc-
ing and Analysis Consortium [6] was translated from Ent-
rez gene entries to Ensembl gene IDs [33]. This dataset
was merged with the set of dominant and recessive OMIM
disease genes compiled earlier. This resulted in a non-
redundant dataset of 886 disease genes, consisting of 367
dominant disease (DD) and 519 recessive disease (DR)
genes, and 10,914 "non-disease" (nD) genes. Substitution
rates KA, KS and KI data for the genes were taken from the
Chimpanzee Sequencing and Analysis Consortium sup-
plementary data [6]. KA/KS values for gene datasets were
calculated by summing up over all non-synonymous and
synonymous sites in each dataset as reported elsewhere
[6]. Mann-Whitney and Kolmogorov-Smirnov tests were
conducted using the KA, KS and KI data for each individual
gene, and for KA/KS by excluding genes where KS = 0.
Essentiality data in C. elegans
C. elegans genes were classified depending on their pheno-
type in RNAi experiments in three groups, Wild Type
(WT), Lethal (L) or Disease (D). RNAi phenotypes were
extracted from Wormbase Biomart [17]. We mapped the
human orthologue of each C. elegans gene using ortho-
logues pairwise data from Ensembl Compara [39]. The
number of human genes corresponding to WT, L or D
phenotypes in the RNAi experiments in C. elegans was
counted for each of the groups analysed (DD, DR and
nD).
Evolutionary rates per functional classification
The dominant and recessive disease genes were classified
according to the molecular function of each protein as
determined by the Gene Ontology "slim" terms [18]. Pro-
tein conservation scores in mouse and paralogues were
calculated as described previously. KA/KS values were cal-
culated for each gene dataset by summing up over all non-
synonymous and synonymous sites in each dataset.
Evolutionary rates per severity of disease
Data on the severity of disease genes were obtained from
Jimenez-Sanchez et al. [1]. In total 303 genes in our set
were classified in one of the following groups according to
disease severity: None, Mild (death >60 years), Moderate
(death between puberty and 60), and Severe (death before
puberty). KA/KS values for each group of genes were calcu-
lated as explained before.
Gene structure analysis
Gene length, coding sequence length and number of
introns were obtained from Ensembl database [33]. The
number of alternative transcripts was obtained from Alter-
native Splicing Database [40]. Differences in these
sequences properties between different groups (D, nD,
DD and DR) were assessed using the Kolmogorov-Smir-
nov test.
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